Targeting senescent cells: approaches, opportunities, challenges
Open accessThe DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Abstract
Cellular senescence is a hallmark of aging, whose onset is linked to a series of both cell and non-cell autonomous processes, leading to several consequences for the organism. To date, several senescence routes have been identified, which play a fundamental role in development, tumor suppression and aging, among other processes. The positive and/or negative effects of senescent cells are directly related to the time that they remain in the organism. Short-term (acute) senescent cells are associated with positive effects; once they have executed their actions, immune cells are recruited to remove them. In contrast, long-term (chronic) senescent cells are associated with disease; they secrete pro-inflammatory and pro-tumorigenic factors in a state known as senescence-associated secretory phenotype (SASP). In recent years, cellular senescence has become the center of attention for the treatment of aging-related diseases. Current therapies are focused on elimination of senescent cell functions in three main ways: i) use of senolytics; ii) inhibition of SASP; and iii) improvement of immune system functions against senescent cells (immunosurveillance). In addition, some anti-cancer therapies are based on the induction of senescence in tumor cells. However, these senescent-like cancer cells must be subsequently cleared to avoid a chronic pro-tumorigenic state. Here is a summary of different scenarios, depending on the therapy used, with a discussion of the pros and cons of each scenario.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013) · Cell · doi:10.1016/j.cell.2013.05.039 · Cited by 14,982
The serial cultivation of human diploid cell strains
Hayflick, L., & Moorhead, P. S. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90192-6 · Cited by 8,508 · cited 1×
“First described in cultured human diploid fibroblasts after successive rounds of division [2], its main hallmarks are irreversible growth arrest, alterations of cell size and morphology, increased lysosomal activity, expression of anti-proliferative proteins, resistance to apoptosis, activation of damagesensing signal…”
BackgroundThe senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670
Naturally occurring p16Ink4a-positive cells shorten healthy lifespan
Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., et al. (2016) · Nature · doi:10.1038/nature16932 · Cited by 2,876
Cellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818
The role of senescent cells in ageing
van Deursen, J. M. (2014) · Nature · doi:10.1038/nature13193 · Cited by 2,623 · cited 1×
“The role of the immune system in the elimination of senescent cells is fundamental, and a decline in immune function is associated with an increase in the number of senescent cells and finally, disease (Figure 4, step 4) [12, 20, 79, 80].”
BackgroundThe Achilles' heel of senescent cells: from transcriptome to senolytic drugs
Zhu, Y., Tchkonia, T., Pirtskhalava, T., Gower, A. C., Ding, H., Giorgadze, N., Palmer, A. K., Ikeno, Y., Hubbard, G. B., Lenburg, M., et al. (2015) · Aging Cell · doi:10.1111/acel.12344 · Cited by 2,584 · cited 2×
“Dasatinib (D) Inhibitor EFNB*-dependent suppression of apoptosis [51]”
BackgroundCellular senescence in aging and age-related disease: from mechanisms to therapy
Childs, B. G., Durik, M., Baker, D. J., & van Deursen, J. M. (2015) · Nature Medicine · doi:10.1038/nm.4000 · Cited by 2,363 · cited 1×
“com 12845 AGING cancer stop tumor growth while causing accumulation of senescent cells [13, 14], which subsequently become a problem for the organism [15].”
BackgroundSenolytics improve physical function and increase lifespan in old age
Xu, M., Pirtskhalava, T., Farr, J. N., Weigand, B. M., Palmer, A. K., Weivoda, M. M., Inman, C. L., Ogrodnik, M. B., Hachfeld, C. M., Fraser, D. G., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0092-9 · Cited by 2,287
Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086
Senescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice
Chang, J., Wang, Y., Shao, L., Laberge, R.-M., Demaria, M., Campisi, J., Janakiraman, K., Sharpless, N. E., Ding, S., Feng, W., et al. (2016) · Nature Medicine · doi:10.1038/nm.4010 · Cited by 1,819 · cited 1×
“ABT 263 (Navitoclax; UBX0101) BCL-2, BCL-XL and BCL-W inhibitors [37, 53, 54]”
Cellular senescence and the senescent secretory phenotype: therapeutic opportunities
Tchkonia, T., Zhu, Y., van Deursen, J., Campisi, J., & Kirkland, J. L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64098 · Cited by 1,774 · cited 1×
“Another strategy to inhibit the functions of senescent cells is through the specific silencing of SASP [16, 46], the complex mixture of soluble factors such as cytokines, chemokines, growth factors, proteases and angiogenic factors that mediates the paracrine and autocrine functions of senescent cells [3, 25] (Figure…”
BackgroundSenescence in Health and Disease
He, S., & Sharpless, N. E. (2017) · Cell · doi:10.1016/j.cell.2017.05.015 · Cited by 1,766
Cellular senescence mediates fibrotic pulmonary disease
Schafer, M. J., White, T. A., Iijima, K., Haak, A. J., Ligresti, G., Atkinson, E. J., Oberg, A. L., Birch, J., Salmonowicz, H., Zhu, Y., et al. (2017) · Nature Communications · doi:10.1038/ncomms14532 · Cited by 1,613 · cited 1×
“Tissues from IPF patients display some phenotypical characteristics of senescent cells, and when these cells were removed by senolytics, pulmonary functions improved [104].”
BackgroundJeon, O. H., Kim, C., Laberge, R.-M., Demaria, M., Rathod, S., Vasserot, A. P., Chung, J. W., Kim, D. H., Poon, Y., David, N., et al. (2017) · Nature Medicine · doi:10.1038/nm.4324 · Cited by 1,515 · cited 3×
“Arthritis has also been causally associated with the presence of senescent cells [37].”
BackgroundBaar, M. P., Brandt, R. M. C., Putavet, D. A., Klein, J. D. D., Derks, K. W. J., Bourgeois, B. R. M., Stryeck, S., Rijksen, Y., van Willigenburg, H., Feijtel, D. A., et al. (2017) · Cell · doi:10.1016/j.cell.2017.02.031 · Cited by 1,454
Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline
Bussian, T. J., Aziz, A., Meyer, C. F., Swenson, B. L., van Deursen, J. M., & Baker, D. J. (2018) · Nature · doi:10.1038/s41586-018-0543-y · Cited by 1,289 · cited 2×
“Neurodegenerative disorders Senescent cell accumulation has been detected at sites of brain pathology [7, 32, 33].”
BackgroundSenescent cells: an emerging target for diseases of ageing
Childs, B. G., Gluscevic, M., Baker, D. J., Laberge, R.-M., Marquess, D., Dananberg, J., & van Deursen, J. M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.116 · Cited by 1,284
Senescence and aging: Causes, consequences, and therapeutic avenues
McHugh, D., & Gil, J. (2018) · Journal of Cell Biology · doi:10.1083/jcb.201708092 · Cited by 1,233 · cited 8×
“further release pro-inflammatory factors in an alreadydamaged tissue) [10].”
BackgroundInfluentialLaberge, R.-M., Sun, Y., Orjalo, A. V., Patil, C. K., Freund, A., Zhou, L., Curran, S. C., Davalos, A. R., Wilson-Edell, K. A., Liu, S., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3195 · Cited by 1,160 · cited 1×
“Rapamycin mTOR inhibitor, membrane-bound IL-1A translation inhibition, prelamin A, 53BP1 [73] [74] [110]”
Zhu, Y., Tchkonia, T., Fuhrmann‐Stroissnigg, H., Dai, H. M., Ling, Y. Y., Stout, M. B., Pirtskhalava, T., Giorgadze, N., Johnson, K. O., Giles, C. B., et al. (2016) · Aging Cell · doi:10.1111/acel.12445 · Cited by 1,148 · cited 1×
“ABT 263 (Navitoclax; UBX0101) BCL-2, BCL-XL and BCL-W inhibitors [37, 53, 54]”
Cellular senescence drives age-dependent hepatic steatosis
Ogrodnik, M., Miwa, S., Tchkonia, T., Tiniakos, D., Wilson, C. L., Lahat, A., Day, C. P., Burt, A., Palmer, A., Anstee, Q. M., et al. (2017) · Nature Communications · doi:10.1038/ncomms15691 · Cited by 1,044
Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL
Yosef, R., Pilpel, N., Tokarsky-Amiel, R., Biran, A., Ovadya, Y., Cohen, S., Vadai, E., Dassa, L., Shahar, E., Condiotti, R., et al. (2016) · Nature Communications · doi:10.1038/ncomms11190 · Cited by 1,032
Cellular senescence: a translational perspective
Kirkland, J. L., & Tchkonia, T. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.04.013 · Cited by 1,013
DePinho, R. A. (2000) · Nature · doi:10.1038/35041694 · Cited by 951
Cellular senescence and its effector programs
Salama, R., Sadaie, M., Hoare, M., & Narita, M. (2014) · Genes & Development · doi:10.1101/gad.235184.113 · Cited by 855
Therapy-induced senescence in cancer.
Ewald, J. A., Desotelle, J. A., Wilding, G., & Jarrard, D. F. (2010) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djq364 · Cited by 824
mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype
Herranz, N., Gallage, S., Mellone, M., Wuestefeld, T., Klotz, S., Hanley, C. J., Raguz, S., Acosta, J. C., Innes, A. J., Banito, A., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3225 · Cited by 788 · cited 1×
“Rapamycin mTOR inhibitor, membrane-bound IL-1A translation inhibition, prelamin A, 53BP1 [73] [74] [110]”
Zhu, Y., Doornebal, E. J., Pirtskhalava, T., Giorgadze, N., Wentworth, M., Fuhrmann-Stroissnigg, H., Niedernhofer, L. J., Robbins, P. D., Tchkonia, T., & Kirkland, J. L. (2017) · Aging · doi:10.18632/aging.101202 · Cited by 757
Identification of HSP90 inhibitors as a novel class of senolytics
Fuhrmann-Stroissnigg, H., Ling, Y. Y., Zhao, J., McGowan, S. J., Zhu, Y., Brooks, R. W., Grassi, D., Gregg, S. Q., Stripay, J. L., Dorronsoro, A., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00314-z · Cited by 701
Reversal of persistent fibrosis in aging by targeting Nox4-Nrf2 redox imbalance
Hecker, L., Logsdon, N. J., Kurundkar, D., Kurundkar, A., Bernard, K., Hock, T., Meldrum, E., Sanders, Y. Y., & Thannickal, V. J. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008182 · Cited by 686 · cited 1×
“Thus, alternative therapies should be kept in mind to treat senescence-associated fibrosis [101].”
BackgroundOrjalo, A. V., Bhaumik, D., Gengler, B. K., Scott, G. K., & Campisi, J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905299106 · Cited by 654
Moiseeva, O., Deschênes‐Simard, X., St‐Germain, E., Igelmann, S., Huot, G., Cadar, A. E., Bourdeau, V., Pollak, M. N., & Ferbeyre, G. (2013) · Aging Cell · doi:10.1111/acel.12075 · Cited by 654
Targeting senescent cells enhances adipogenesis and metabolic function in old age
Xu, M., Palmer, A. K., Ding, H., Weivoda, M. M., Pirtskhalava, T., White, T. A., Sepe, A., Johnson, K. O., Stout, M. B., Giorgadze, N., et al. (2015) · eLife · doi:10.7554/elife.12997 · Cited by 604
Tau protein aggregation is associated with cellular senescence in the brain
Musi, N., Valentine, J. M., Sickora, K. R., Baeuerle, E., Thompson, C. S., Shen, Q., & Orr, M. E. (2018) · Aging Cell · doi:10.1111/acel.12840 · Cited by 595 · cited 3×
“Conversely, local injections of senescent cells drive aging-related diseases [8, 9].”
BackgroundImpaired immune surveillance accelerates accumulation of senescent cells and aging
Ovadya, Y., Landsberger, T., Leins, H., Vadai, E., Gal, H., Biran, A., Yosef, R., Sagiv, A., Agrawal, A., Shapira, A., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07825-3 · Cited by 578
Liu, D., & Hornsby, P. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3452 · Cited by 499
The molecular targets of resveratrol
Kulkarni, S. S., & Cantó, C. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.10.005 · Cited by 477
Ageing, Cellular Senescence and Neurodegenerative Disease
Kritsilis, M., V. Rizou, S., Koutsoudaki, P. N., Evangelou, K., Gorgoulis, V. G., & Papadopoulos, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102937 · Cited by 448 · cited 2×
“Neurodegenerative disorders Senescent cell accumulation has been detected at sites of brain pathology [7, 32, 33].”
BackgroundNK cell–mediated cytotoxicity contributes to tumor control by a cytostatic drug combination
Ruscetti, M., Leibold, J., Bott, M. J., Fennell, M., Kulick, A., Salgado, N. R., Chen, C.-C., Ho, Y.-J., Sanchez-Rivera, F. J., Feucht, J., et al. (2018) · Science · doi:10.1126/science.aas9090 · Cited by 415
The role of chondrocyte senescence in osteoarthritis
Price, J. S., Waters, J. G., Darrah, C., Pennington, C., Edwards, D. R., Donell, S. T., & Clark, I. M. (2002) · Aging Cell · doi:10.1046/j.1474-9728.2002.00008.x · Cited by 386
p16Ink4a-induced senescence of pancreatic beta cells enhances insulin secretion
Helman, A., Klochendler, A., Azazmeh, N., Gabai, Y., Horwitz, E., Anzi, S., Swisa, A., Condiotti, R., Granit, R. Z., Nevo, Y., et al. (2016) · Nature Medicine · doi:10.1038/nm.4054 · Cited by 351 · cited 1×
“Senescent β-cells affect glucose homeostasis, although further work is needed to elucidate the exact role of senescence [20, 38, 39].”
BackgroundA versatile drug delivery system targeting senescent cells
Muñoz‐Espín, D., Rovira, M., Galiana, I., Giménez, C., Lozano‐Torres, B., Paez‐Ribes, M., Llanos, S., Chaib, S., Muñoz‐Martín, M., Ucero, A. C., et al. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201809355 · Cited by 339 · cited 5×
“To date there is no universal marker for senescence, and identification of senescent cells is based on the combined detection of two or more phenotypic aspects mentioned above, such as SA-β-Gal, p16Ink4a or p21WAF1 [10].”
BackgroundInfluentialCoppé, J.-P., Patil, C. K., Rodier, F., Sun, Y., Muñoz, D. P., Goldstein, J., Nelson, P. S., Desprez, P.-Y., & Campisi, J. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060301 · Cited by 302 · cited 4×
“Another important characteristic is the regulated secretion of interleukins (ILs), inflammatory factors, termed the senescenceassociated secretory phenotype (SASP) [3].”
BackgroundInfluentialCellular senescence and the aging brain
Chinta, S. J., Woods, G., Rane, A., Demaria, M., Campisi, J., & Andersen, J. K. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2014.09.018 · Cited by 282 · cited 1×
“The presence of senescent astrocytes correlates with the onset of pathologies such as Parkinson’s and Alzheimer’s disease [34].”
BackgroundIdentification of senescent cell surface targetable protein DPP4
Kim, K. M., Noh, J. H., Bodogai, M., Martindale, J. L., Yang, X., Indig, F. E., Basu, S. K., Ohnuma, K., Morimoto, C., Johnson, P. F., et al. (2017) · Genes & Development · doi:10.1101/gad.302570.117 · Cited by 270 · cited 1×
“In this sense the recent identification of a targetable senescent cell surface marker supports this strategy [85].”
BackgroundRobust, universal biomarker assay to detect senescent cells in biological specimens
Evangelou, K., Lougiakis, N., Rizou, S. V., Kotsinas, A., Kletsas, D., Muñoz‐Espín, D., Kastrinakis, N. G., Pouli, N., Marakos, P., Townsend, P., et al. (2017) · Aging Cell · doi:10.1111/acel.12545 · Cited by 259 · cited 1×
“Although novel technologies are making detection of senescent cells in tissues more reliable [92, 93], the use of a combination of different biomarkers is still necessary for confirmation.”
BackgroundTumor cell escape from therapy-induced senescence as a model of disease recurrence after dormancy.
Saleh, T., Tyutyunyk-Massey, L., & Gewirtz, D. A. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3437 · Cited by 259 · cited 1×
“Although it seems to be a rare event, it occurs [99, 100].”
BackgroundSwanson, E. C., Manning, B., Zhang, H., & Lawrence, J. B. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201306073 · Cited by 251
Senescent cells: SASPected drivers of age-related pathologies
Ovadya, Y., & Krizhanovsky, V. (2014) · Biogerontology · doi:10.1007/s10522-014-9529-9 · Cited by 232
Reversible Senescence in Human CD4+CD45RA+CD27− Memory T Cells
Di Mitri, D., Azevedo, R. I., Henson, S. M., Libri, V., Riddell, N. E., Macaulay, R., Kipling, D., Soares, M. V. D., Battistini, L., & Akbar, A. N. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100978 · Cited by 231
Glucocorticoids suppress selected components of the senescence‐associated secretory phenotype
Laberge, R., Zhou, L., Sarantos, M. R., Rodier, F., Freund, A., de Keizer, P. L. J., Liu, S., Demaria, M., Cong, Y., Kapahi, P., et al. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00818.x · Cited by 229
Two-Step Senescence-Focused Cancer Therapies
Sieben, C. J., Sturmlechner, I., van de Sluis, B., & van Deursen, J. M. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.04.006 · Cited by 222
Cellular senescence: Immunosurveillance and future immunotherapy
Burton, D. G. A., & Stolzing, A. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.02.001 · Cited by 221 · cited 2×
“For T cells this process would be mainly mediated by TCRs [84].”
BackgroundCellular senescence: the sought or the unwanted?
Sun, Y., Coppé, J.-P., & Lam, E. W.-F. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.08.002 · Cited by 208 · cited 4×
“Another strategy to inhibit the functions of senescent cells is through the specific silencing of SASP [16, 46], the complex mixture of soluble factors such as cytokines, chemokines, growth factors, proteases and angiogenic factors that mediates the paracrine and autocrine functions of senescent cells [3, 25] (Figure…”
BackgroundInfluentialLim, H., Park, H., & Kim, H. P. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.06.013 · Cited by 205 · cited 3×
“Among the SASP factors that seem responsible for attraction of immune cells are CSF (colony stimulating factor 1), CXCL-1 (chemokine C-X-C motif ligand 1), MCP-1 (monocyte chemoattractant protein 1) and ICAM-1 (intercellular adhesion molecule 1) [25].”
BackgroundStrategies targeting cellular senescence
Ovadya, Y., & Krizhanovsky, V. (2018) · Journal of Clinical Investigation · doi:10.1172/jci95149 · Cited by 200 · cited 1×
“Cell and antibody mediated responses are possible approaches, however, the specificity of senescent antigens would be the bottleneck to avoid undesirable side effects [108].”
Backgroundβ Cell Aging Markers Have Heterogeneous Distribution and Are Induced by Insulin Resistance
Aguayo-Mazzucato, C., van Haaren, M., Mruk, M., Lee, T. B., Crawford, C., Hollister-Lock, J., Sullivan, B. A., Johnson, J. W., Ebrahimi, A., Dreyfuss, J. M., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.03.015 · Cited by 198
Anti-senescence compounds: A potential nutraceutical approach to healthy aging
Gurău, F., Baldoni, S., Prattichizzo, F., Espinosa, E., Amenta, F., Procopio, A. D., Albertini, M. C., Bonafè, M., & Olivieri, F. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.05.001 · Cited by 179
Spatial and Temporal Control of Senescence
Ito, Y., Hoare, M., & Narita, M. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.07.004 · Cited by 178 · cited 1×
“The qualitative and quantitative composition of this secretome is different depending on the cell type and the senescence-inducing stimulus, and becomes fully active a few days after the persistent stimulus [3, 47, 48].”
BackgroundAlimbetov, D., Davis, T., Brook, A. J. C., Cox, L. S., Faragher, R. G. A., Nurgozhin, T., Zhumadilov, Z., & Kipling, D. (2016) · Biogerontology · doi:10.1007/s10522-015-9610-z · Cited by 162
Senescence and senotherapeutics: a new field in cancer therapy
Myrianthopoulos, V., Evangelou, K., Vasileiou, P. V. S., Cooks, T., Vassilakopoulos, T. P., Pangalis, G. A., Kouloukoussa, M., Kittas, C., Georgakilas, A. G., & Gorgoulis, V. G. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.08.006 · Cited by 160 · cited 5×
“These strategies would rely on specific (universal) senescence receptors, and a limiting factor when detecting cell senescence is the lack of universal markers [13].”
BackgroundInfluentialCellular senescence impact on immune cell fate and function
Vicente, R., Mausset-Bonnefont, A.-L., Jorgensen, C., Louis-Plence, P., & Brondello, J.-M. (2016) · Aging Cell · doi:10.1111/acel.12455 · Cited by 151 · cited 2×
“NK cells recognize the CD58/ICAM1 receptor present in senescent cells [83].”
BackgroundSmall-molecule MDM2 antagonists attenuate the senescence-associated secretory phenotype
Wiley, C. D., Schaum, N., Alimirah, F., Lopez-Dominguez, J. A., Orjalo, A. V., Scott, G., Desprez, P.-Y., Benz, C., Davalos, A. R., & Campisi, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-20000-4 · Cited by 124 · cited 1×
“In this sense it is important to mention that MDM2 inhibitors, targeting p53, are also in clinical phases as anti-cancer therapies [45].”
BackgroundGolde, T. E., & Miller, V. M. (2009) · Alzheimer's Research & Therapy · doi:10.1186/alzrt5 · Cited by 98 · cited 1×
“Neurodegenerative disorders Senescent cell accumulation has been detected at sites of brain pathology [7, 32, 33].”
BackgroundGalbiati, A., Beauséjour, C., & d'Adda di Fagagna, F. (2017) · Aging Cell · doi:10.1111/acel.12573 · Cited by 79
Accelerated Aging in HIV/AIDS: Novel Biomarkers of Senescent Human CD8+ T Cells
Chou, J. P., Ramirez, C. M., Wu, J. E., & Effros, R. B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064702 · Cited by 78
The convergence of senescence and nutrient sensing during lymphocyte ageing
Akbar, A. N. (2016) · Clinical and Experimental Immunology · doi:10.1111/cei.12876 · Cited by 23
Research works printed but not linked: 40
- Kirkland, 2017, Transplanted Senescent Cells Induce an Osteoarthritis-Like Condition in Mice., J Gerontol A Biol Sci Med Sci, 7, 780, 10.1093/gerona/glw154 · DOI · Paper page
- Maier, 2012, The number of p16INK4a positive cells in human skin reflects biological age., Aging Cell, 1, 722, 10.1111/j.1474-9726.2012.00837.x · DOI · Paper page
- Demaria, 2016, Targeting Senescent Cells: Possible Implications for Delaying Skin Aging: A Mini-Review., Gerontology, 6, 513, 10.1159/000444877 · DOI · Paper page
- von Kobbe, 2018, Cellular senescence: a view throughout organismal life., Cell Mol Life Sci, 7, 3553, 10.1007/s00018-018-2879-8 · DOI
- Demaria, 2018, Hallmarks of Cellular Senescence., Trends Cell Biol, 2, 436, 10.1016/j.tcb.2018.02.001 · DOI · Paper page
- Chen, 2008, DEC1, a basic helix-loop-helix transcription factor and a novel target gene of the p53 family, mediates p53-dependent premature senescence., J Biol Chem, 28, 2896, 10.1074/jbc.m708624200 · DOI
- Morrison, 2009, Mechanisms of stem cell self-renewal., Annu Rev Cell Dev Biol, 2, 377, 10.1146/annurev.cellbio.042308.113248 · DOI · Paper page
- von Zglinicki, 2019, The bystander effect contributes to the accumulation of senescent cells in vivo., Aging Cell, 1, e12848, 10.1111/acel.12848 · DOI · Paper page
- LeBrasseur, 2018, Targeting Senescent Cells in Fibrosis: Pathology, Paradox, and Practical Considerations., Curr Rheumatol Rep, 2, 3, 10.1007/s11926-018-0712-x · DOI
- de Magalhães, 2013, How ageing processes influence cancer., Nat Rev Cancer, 1, 357, 10.1038/nrc3497 · DOI · Paper page
- van Deursen, 2016, Senescent intimal foam cells are deleterious at all stages of atherosclerosis., Science, 35, 472, 10.1126/science.aaf6659 · DOI · Paper page
- Homma, 2015, Senescent Cells Impair Erectile Function through Induction of Endothelial Dysfunction and Nerve Injury in Mice., PLoS One, 1, e0124129, 10.1371/journal.pone.0124129 · DOI
- McKeegan, 2012, Phase II study of single-agent navitoclax (ABT-263) and biomarker correlates in patients with relapsed small cell lung cancer., Clin Cancer Res, 1, 3163, 10.1158/1078-0432.CCR-11-3090 · DOI · Paper page
- Alimonti, 2016, Non-Cell-Autonomous Regulation of Cellular Senescence in Cancer., Trends Cell Biol, 2, 215, 10.1016/j.tcb.2015.10.005 · DOI
- van der Meer, 2012, Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases., Nat Rev Drug Discov, 1, 633, 10.1038/nrd3800 · DOI · Paper page
- Donath, 2015, Safety, pharmacokinetics, and preliminary efficacy of a specific anti-IL-1alpha therapeutic antibody (MABp1) in patients with type 2 diabetes mellitus., J Diabetes Complications, 2, 955, 10.1016/j.jdiacomp.2015.05.019 · DOI
- Burotto, 2017, MABp1 for the treatment of colorectal cancer., Expert Opin Biol Ther, 1, 1155, 10.1080/14712598.2017.1347631 · DOI
- Wilson, 2008, The interleukin-8 pathway in cancer., Clin Cancer Res, 1, 6735, 10.1158/1078-0432.CCR-07-4843 · DOI · Paper page
- Soth, 2010, Selective p38alpha inhibitors clinically evaluated for the treatment of chronic inflammatory disorders., J Med Chem, 5, 2345, 10.1021/jm9012906 · DOI · Paper page
- Giovannelli, 2013, Chronic resveratrol treatment ameliorates cell adhesion and mitigates the inflammatory phenotype in senescent human fibroblasts., J Gerontol A Biol Sci Med Sci, 6, 371, 10.1093/gerona/gls183 · DOI · Paper page
- Baldwin, 2000, Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IkappaB kinase., Cancer Res, 6, 3477
- Chiu, 2019, Metformin Targets Mitochondrial Electron Transport to Reduce Air-Pollution-Induced Thrombosis., Cell Metab, 2, 335, 10.1016/j.cmet.2018.09.019 · DOI · Paper page
- Nonell-Canals, 2018, Metformin directly targets the H3K27me3 demethylase KDM6A/UTX., Aging Cell, 1, e12772, 10.1111/acel.12772 · DOI · Paper page
- Klubo-Gwiezdzinska, 2018, Metformin Targets Mitochondrial Glycerophosphate Dehydrogenase to Control Rate of Oxidative Phosphorylation and Growth of Thyroid Cancerand, Clin Cancer Res, 2, 4030, 10.1158/1078-0432.CCR-17-3167 · DOI
- Carling, 2002, The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways., J Biol Chem, 27, 25226, 10.1074/jbc.M202489200 · DOI · Paper page
- Franceschi, 2014, Lamins are rapamycin targets that impact human longevity: a study in centenarians., J Cell Sci, 12, 147, 10.1242/jcs.133983 · DOI
- Wolf, 2016, The JAK inhibitor ruxolitinib impairs dendritic cell migration via off-target inhibition of ROCK., Leukemia, 3, 2119, 10.1038/leu.2016.155 · DOI
- Lawson, 2014, Discovery and characterization of olokizumab: a humanized antibody targeting interleukin-6 and neutralizing gp130-signaling., MAbs, 6, 774, 10.4161/mabs.28612 · DOI
- Wu, 2017, Chimeric antigen receptor T cells: a novel therapy for solid tumors., J Hematol Oncol, 1, 78, 10.1186/s13045-017-0444-9 · DOI · Paper page
- von Kobbe, 2012, Chimeric infectious bursal disease virus-like particles as potent vaccines for eradication of established HPV-16 E7-dependent tumors., PLoS One, 7, e52976, 10.1371/journal.pone.0052976 · doi:10.1371/journal.pone.0052976
- Bachmann, 2006, A second vaccine revolution for the new epidemics of the 21st century., Drug Discov Today, 1, 1028, 10.1016/j.drudis.2006.09.006 · DOI
- Mavroudis, 2012, Immunological responses in cancer patients after vaccination with the therapeutic telomerase-specific vaccine Vx-001., Cancer Immunol Immunother, 6, 157, 10.1007/s00262-011-1093-4 · DOI
- Sparwasser, 2016, Immunometabolism and autoimmunity., Immunol Cell Biol, 9, 925, 10.1038/icb.2016.77 · DOI
- Yang, 2019, Dysfunction of immune system in the development of large granular lymphocyte leukemia., Hematology, 2, 139, 10.1080/10245332.2018.1535294 · DOI
- Rodier, 2016, Premature aging/senescence in cancer cells facing therapy: good or bad?, Biogerontology, 1, 71, 10.1007/s10522-015-9593-9 · DOI
- Gewirtz, 2019, Tumor cell escape from therapy-induced senescence., Biochem Pharmacol, 16, 202, 10.1016/j.bcp.2018.12.013 · DOI · Paper page
- Department of Economic and Social Affairs (DESA), 2015, World population ageing.
- Yao, 2016, Effects of senescent lens epithelial cells on the severity of age-related cortical cataract in humans: A case-control study., Medicine (Baltimore), 9, e3869, 10.1097/MD.0000000000003869 · DOI
- Minamino, 2014, Inhibition of endothelial p53 improves metabolic abnormalities related to dietary obesity., Cell Rep, 7, 1691, 10.1016/j.celrep.2014.04.046 · DOI · Paper page
- Spector, 1995, Oxidative stress-induced cataract: mechanism of action., FASEB J, 9, 1173, 10.1096/fasebj.9.12.7672510 · DOI · Paper page
Cited by
Lagoumtzi, S. M., & Chondrogianni, N. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.05.003 · Cited by 279
Secomandi, L., Borghesan, M., Velarde, M., & Demaria, M. (2022) · Human Reproduction Update · doi:10.1093/humupd/dmab038 · Cited by 208
“Alternatively, neutralizing antibodies can be administered against individual SASP factors, such as IL1a, IL-8 and IL-6, for higher specificity (von Kobbe, 2019).”
Senescence in Wound Repair: Emerging Strategies to Target Chronic Healing Wounds
Wilkinson, H. N., & Hardman, M. J. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00773 · Cited by 173
Metformin targets mitochondrial electron transport to reduce air-pollution-induced thrombosis
Soberanes, S., Misharin, A. V., Jairaman, A., Morales-Nebreda, L., McQuattie-Pimentel, A. C., Cho, T., Hamanaka, R. B., Meliton, A. Y., Reyfman, P. A., Walter, J. M., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2018.09.019 · Cited by 131
The Emergence of Senescent Surface Biomarkers as Senotherapeutic Targets
Rossi, M., & Abdelmohsen, K. (2021) · Cells · doi:10.3390/cells10071740 · Cited by 71
Metadata
- Authors
- von Kobbe, C.
- Venue
- Aging
- Publisher
- Impact Journals, LLC
- Published
- 2019-11-30
- Volume
- 11
- Issue
- 24
- Pages
- 12844-12861
- ISSN
- 1945-4589 (ISSN-L)
- OpenAlex
- W2992558821
- Cited by
- 127
- References
- 70
- FWCI
- 8.00
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.